-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels: Characteristics of Brain In Situ Models
Author:
InnoModels
Release time:
2024-03-08
Understanding the complex functions of the brain and disease mechanisms has always been a major challenge in neuroscience research. As technology continues to advance, the emergence of Biologically Accurate Brain Models (BAMs) from InnoModels Biotechnology has opened up new avenues for research in this field. Such models provide a powerful tool for neuroscience research with their high degree of simulation and accuracy.
Highly Simulatable
One of the most important features of TInnoModels' in situ brain models is their high degree of simulation. These models are able to simulate the structure and function of the real brain, including the morphology of neurons, synaptic connections, neural network activity, and more. This high degree of simulation allows researchers to conduct more in-depth and systematic studies of the brain in the laboratory without the need for high-risk in vivo experiments.
Controllability
Compared with traditional animal experiments, InnoModels' in situ brain models are highly controllable. Researchers can adjust the parameters and conditions of the model to simulate different physiological and pathological states, thus studying brain functions and disease mechanisms more precisely. This controllability not only improves the accuracy and reliability of experiments, but also provides a more effective experimental platform for drug development and therapeutic approaches.

Reproducibility
Another important feature of InnoModels' in situ brain model is its reproducibility. Due to the high simulation and controllability of the model, researchers can repeat the same experiments in different laboratories and over different time periods, thus validating and comparing research results. This reproducibility not only improves the credibility of the research, but also facilitates international cooperation and exchange.
Wide range of application areas
InnoModels' in situ brain model has a wide range of applications in neuroscience research. It can be used to study the normal physiological functions of the brain, such as development, aging, learning and memory, and can also be used to simulate and study various neurological disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia and so on. In addition, the model can provide an important reference and basis for drug development, selection and optimization of therapeutic methods.
Challenges and Prospects
Despite the many advantages and application prospects of the InnoModels Biotechnology Brain In Situ Model, it still faces some challenges in practical application. For example, the construction and maintenance of the model is costly, technically difficult, and requires specialized knowledge and skills. In addition, due to the complexity and diversity of the brain, it is still a great challenge to fully simulate the function and structure of the real brain.
However, with the continuous advancement of technology and in-depth research, we have reason to believe that the brain in-situ model of InnoModels Biotechnology will play an even more important role in the future. With the continuous development of material science, computer science and biotechnology, we can expect the emergence of more advanced and more accurate models to provide more powerful support for neuroscience research.
In conclusion, as an important tool for neuroscience research, the high simulation, controllability, reproducibility and wide application prospects of the brain in situ model of InnoModels Biotechnology have made it a hotspot and frontier in the current neuroscience research field. With the continuous progress of technology and the expansion of application fields, we have reason to believe that more remarkable results and breakthroughs will be achieved in this field.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd